Efficacy of Combination Vedolizumab and Ustekinumab for Refractory Crohn's Disease

被引：24
作者：
Huff-Hardy, Kayci [1 ]
Bedair, Mai [2 ]
Vazquez, Rebecca [2 ]
Burstein, Ezra [1 ]
机构：
[1] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[2] UT Southwestern Med Ctr, Dept Dermatol, Dallas, TX USA
来源：
INFLAMMATORY BOWEL DISEASES | 2017年 / 23卷 / 10期
关键词：
MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1097/MIB.0000000000001232
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E49 / E49
页数：1
相关论文
共 50 条
  • [21] An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors
    Onali, Sara
    Pugliese, Daniela
    Caprioli, Flavio Andrea
    Orlando, Ambrogio
    Biancone, Livia
    Nardone, Olga Maria
    Imperatore, Nicola
    Fiorino, Gionata
    Cappello, Maria
    Viola, Anna
    Principi, Maria Beatrice
    Bezzio, Cristina
    Aratari, Annalisa
    Carparelli, Sonia
    Mazzuoli, Silvia
    Manguso, Francesco
    Grossi, Laurino
    Bodini, Giorgia
    Ribaldone, Davide
    Mocci, Giammarco
    Miranda, Agnese
    Minerba, Luigi
    Favale, Agnese
    Grova, Mauro
    Scucchi, Ludovica
    Segato, Simone
    Fries, Walter
    Castiglione, Fabiana
    Armuzzi, Alessandro
    Fantini, Massimo C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (08) : 1279 - 1287
  • [22] Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease: results from a multicentre cohort study
    Bacsur, Peter
    Matuz, Maria
    Resal, Tamas
    Miheller, Pal
    Szamosi, Tamas
    Schafer, Eszter
    Sarlos, Patricia
    Ilias, Akos
    Szanto, Kata
    Rutka, Mariann
    Balint, Anita
    Milassin, Agnes
    Fabian, Anna
    Bor, Renata
    Szepes, Zoltan
    Molnar, Tamas
    Farkas, Klaudia
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [23] Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies
    Pasta, Andrea
    Calabrese, Francesco
    Marabotto, Elisa
    Furnari, Manuele
    Demarzo, Maria Giulia
    Pellegrino, Raffaele
    Gravina, Antonietta Gerarda
    Federico, Alessandro
    Giannini, Edoardo Giovanni
    Bodini, Giorgia
    DISEASES, 2024, 12 (11)
  • [24] An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients
    Kawalec, Pawel
    Mocko, Pawel
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (02) : 101 - 111
  • [25] Australian consensus on ustekinumab in Crohn's disease
    Begun, J.
    An, Y-K
    Bryant, R.
    Christensen, B.
    Leong, R.
    Studd, C.
    Thin, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 136 - 137
  • [26] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease
    Christensen, Britt
    Gibson, Peter R.
    Micic, Dejan
    Colman, Ruben J.
    Goeppinger, Sarah R.
    Kassim, Olufemi
    Yarur, Andres
    Weber, Christopher R.
    Cohen, Russell D.
    Rubin, David T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 486 - 493
  • [27] Editorial: accumulating data about ustekinumab in refractory Crohn's disease in real world experience
    Khorrami, S.
    Gisbert, J. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (10) : 1374 - 1375
  • [28] Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn's disease
    Newman, Kira L. L.
    Johnson, Laura A. A.
    Stidham, Ryan W. W.
    Higgins, Peter D. R.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [29] Experience Using Ustekinumab in Pediatric Patients With Medically Refractory Crohn Disease
    Kim, Francis S.
    Patel, Perseus, V
    Stekol, Emily
    Ali, Sabina
    Hamandi, Hassan
    Heyman, Melvin B.
    Verstraete, Sofia G.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 73 (05) : 610 - 614
  • [30] Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease
    Rutgeerts, Paul
    Gasink, Christopher
    Chan, Daphne
    Lang, Yinghua
    Pollack, Paul
    Colombel, Jean-Frederic
    Wolf, Douglas C.
    Jacobstein, Douglas
    Johanns, Jewel
    Szapary, Philippe
    Adedokun, Omoniyi J.
    Feagan, Brian G.
    Sandborn, William J.
    GASTROENTEROLOGY, 2018, 155 (04) : 1045 - 1058
12345